Novartis offers cut-price drugs
The move by Swiss-based Novartis to make its revolutionary new cancer treatment available to Americans regardless of income will intensify demands on the pharmaceutical industry to provide more
The move by Swiss-based Novartis to make its revolutionary new cancer treatment available to Americans regardless of income will intensify demands on the pharmaceutical industry to provide more